Alivaisi Elahe, Amini Sabrieh, Haghani Karimeh, Ghaneialvar Hori, Keshavarzi Fatemeh
Department of Biology, Sanandaj Branch, Islamic Azad University, Sanandaj, Iran.
Department of Clinical Biochemistry, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Biochem Biophys Rep. 2024 Nov 23;40:101882. doi: 10.1016/j.bbrep.2024.101882. eCollection 2024 Dec.
This study investigated the effects of metformin, high-intensity interval training (HIIT), and moderate-intensity continuous training (MCT) on miR-133a expression in a diabetic rat model. miR-133a, a microRNA associated with skeletal muscle insulin resistance, served as a key indicator of treatment efficacy. Diabetic rats exhibited elevated miR-133a levels compared to healthy controls. Both HIIT and MCT, alone and in combination with metformin, significantly reduced miR-133a expression. Importantly, the combination of HIIT and metformin demonstrated the most potent effect, reducing miR-133a levels more than other treatments. We used the CatBoost algorithm to develop a predictive model for miR-133a expression based on metabolic parameters. The model accurately predicted miR-133a levels using body weight, blood glucose, insulin levels, and cholesterol metrics. The findings suggest a potential clinical strategy combining metformin and exercise, with miR-133a potentially serving as a biomarker for personalized diabetes management.
本研究在糖尿病大鼠模型中探究了二甲双胍、高强度间歇训练(HIIT)和中等强度持续训练(MCT)对miR-133a表达的影响。miR-133a是一种与骨骼肌胰岛素抵抗相关的微小RNA,作为治疗效果的关键指标。与健康对照组相比,糖尿病大鼠的miR-133a水平升高。HIIT和MCT单独使用以及与二甲双胍联合使用时,均能显著降低miR-133a的表达。重要的是,HIIT与二甲双胍联合使用显示出最显著的效果,比其他治疗方法更能降低miR-133a水平。我们使用CatBoost算法基于代谢参数建立了一个miR-133a表达的预测模型。该模型利用体重、血糖、胰岛素水平和胆固醇指标准确预测了miR-133a水平。研究结果提示了一种将二甲双胍与运动相结合的潜在临床策略,miR-133a可能作为个性化糖尿病管理的生物标志物。